Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 9.49
- Piotroski Score 4.00
- Grade Buy
- Symbol (CLPT)
- Company ClearPoint Neuro, Inc.
- Price $11.16
- Changes Percentage (1.83%)
- Change $0.2
- Day Low $10.85
- Day High $11.19
- Year High $14.13
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $12.00
- High Stock Price Target $15.00
- Low Stock Price Target $9.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.83
- Trailing P/E Ratio -6.77
- Forward P/E Ratio -6.77
- P/E Growth -6.77
- Net Income $-22,089,000
Income Statement
Quarterly
Annual
Latest News of CLPT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
ClearPoint Neuro released mixed third-quarter results, with revenues slightly exceeding estimates but losses larger than predicted. Analysts revised their forecasts, anticipating a 27% revenue increas...
By Yahoo! Finance | 1 week ago -
ClearPoint Neuro, Inc. (CLPT): A Bear Case Theory
ClearPoint Neuro, Inc. (CLPT) faces a bearish outlook due to overvaluation, weak financials, and tough competition in the neurosurgery market. Analysts recommend shorting CLPT with a price target of $...
By Yahoo! Finance | 1 month ago
